Atlas Trials

Hyperlipoproteinemias

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hyperlipoproteinemias

RecordFirmDate
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. (NCT05425745)NewAmsterdam Pharma2022-07-25
Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. (NCT06163443)S.LAB (SOLOWAYS)2022-03-02
A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) (NCT04516291)Pfizer2020-09-28
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia (NCT00694109)Kastle Therapeutics, LLC2008-04-01
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (NCT00607373)Kastle Therapeutics, LLC2007-07-01
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia (NCT00477594)Kastle Therapeutics, LLC2007-05-01

Track Hyperlipoproteinemias automatically

Every clearance here is in the API, with alerts when new ones post.